A new study finds no evidence of vertical transmissions of SARS-CoV-2 from mother to child during pregnancy, but there appears to be limited transplacental transfer of anti-SARS-CoV-2 antibodies to the neonates in utero.
Patients with high cardiovascular (CV) risk who received a high-dose trivalent influenza vaccine over three influenza seasons did not have a lower risk of cardiopulmonary hospitalization or death compared with those who received a standard-dose quadrivalent vaccine, according to the INVESTED* trial presented at AHA 2020.
Regardless of the scope of work involved, all healthcare workers (HCWs) are similarly stressed by the novel coronavirus disease (COVID-19) pandemic as compared to the general population, according to a Singapore study.
A wearable ring device that can continuously read body temperature appears powerful enough to detect a fever even before it hits, according to a new study. Such a technology may help improve control measures against the novel coronavirus disease (COVID-19).
Collection of nasal epithelial lining fluid (NELF) using nasal strips enables simple, sensitive and low-risk detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparable accuracy vs standard sampling methods, highlighting its potential role in large-scale surveillance of coronavirus disease 2019 (COVID-19) across different age groups in the community.
With the release of the latest interim efficacy results for ChAdOx1 nCoV-19, the adenovirus-vectored vaccine against COVID-19 is inching a step closer towards regulatory approval — and eventually, widespread use that will hopefully put an end to the relentless carnage by the pandemic.
Obesity, particularly the severe class, was associated with an increased risk of mechanical ventilation and death in patients hospitalized with COVID-19 — a risk that is even more profound among the younger age group, reveals data from the AHA COVID-19 CVD registry*.
Rinsing with mouthwash that contains povidone-iodine (PI) or cetylpyridinium chloride (CPC) helps reduce SARS-CoV-2 levels in the saliva of COVID-19 patients, with the effect persisting for up to 6 hours, as shown in a study from Singapore.
Patients with coronavirus disease 2019 (COVID-19) who have haematologic malignancies have a 28 percent mortality rate, according to data collected from 250 patients by the ASH Research Collaborative COVID-19 presented at the 62nd American Society of Hematology Annual Meeting and Exposition (ASH 2020).
An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.
While it is well known that COVID-19 illness is associated with coagulopathy, the optimal anticoagulation strategy remains elusive, and two studies presented at the ASH 2020 Congress further add to the growing debate on the appropriate anticoagulant dose for hospitalized patients with COVID-19.
People are more likely to follow social distancing measures for the novel coronavirus disease (COVID-19) pandemic when they thought that their friends and family did the same, too, according to a new study.